2024 Nasdaq ubx - SAN FRANCISCO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or ...

 
SOUTH SAN FRANCISCO, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse .... Nasdaq ubx

View the latest Unity Biotechnology Inc. (UBX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Nov 18, 2023 · HC Wainwright restated their buy rating on shares of Unity Biotechnology (NASDAQ:UBX – Free Report) in a report published on Tuesday morning, Benzinga reports. HC Wainwright currently has a $10.00 price target on the stock. HC Wainwright also issued estimates for Unity Biotechnology’s Q4 2023 earnings at ($1.15) EPS, FY2024 earnings at ($3.83) EPS, FY2025 […] SOUTH SAN FRANCISCO, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY” or the “Company”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow ... SOUTH SAN FRANCISCO, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...Unity Biotechnology, Inc. (NASDAQ:UBX) was in 4 hedge funds’ portfolios at the end of September. UBX shareholders have witnessed a decrease in hedge fund interest recently. There were 5 hedge ...Unity Biotechnology, Inc. ( NASDAQ:UBX ) shareholders should be happy to see the share price up 23% in the last week...SOUTH SAN FRANCISCO, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ...In the previous quarter, Unity Biotechnology (NASDAQ:UBX) reported ($0.67) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.87) by $0.20. Learn more on analysts' earnings estimate vs. UBX's actual earnings.Source Headline; Unity Biotechnology (UBX) Price Target Increased by 8.33% to 6.63 msn.com - November 27 at 7:50 AM: Unity Biotechnology, Inc. Expected to Post FY2023 Earnings of ($2.66) Per Share (NASDAQ:UBX) americanbankingnews.com - November 20 at 1:26 AM Wedbush Upgrades Unity Biotechnology (UBX) msn.com - …Unity Biotechnology (NASDAQ:UBX) focuses primarily on the development of therapeutics that target age-related ophthalmologic and neurologic diseases. Its central candidate is UBX1325, currently ...HC Wainwright restated their buy rating on shares of Unity Biotechnology (NASDAQ:UBX – Free Report) in a report published on Tuesday morning, Benzinga reports. HC Wainwright currently has a $10.00 price target on the stock. HC Wainwright also issued estimates for Unity Biotechnology’s Q4 2023 earnings at ($1.15) EPS, FY2024 earnings at ($3.83) EPS, FY2025 […]SOUTH SAN FRANCISCO, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ...Pre-Open Stock Movers: Unity Biotechnology Inc (NASDAQ:UBX) 21% HIGHER; Citi raises its price target to $8.00 (from $5.00) while maintaining a Buy rating following Friday's positive data.... Investing.com; Aug 15, 2022 13:21; Pre-Open Movers: Small-cap UNITY Bio Climbs 110%, Alibaba Declines .16th Annual Citi BioPharma Conference on September 8-10, 2021 Morgan Stanley 19th Annual Global Healthcare Conference on September 9-15, 2021 23rd...Unity Biotechnology, Inc. (NASDAQ:UBX) shareholders should be happy to see the share price up 23% in the last month. But only the myopic could ignore the astounding decline over three years.NasdaqGS:UBX Insider Trading Volume May 12th 2021 I will like Unity Biotechnology better if I see some big insider buys. While we wait, check out this free list of growing companies with ...Mar 5, 2023 · Unity Biotechnology, Inc. (NASDAQ: UBX) is a South San Francisco based mid-clinical-stage healthcare concern developing treatments that “ slow, halt, or reverse diseases of aging,” with a ... Unity Biotechnology upgraded to Outperform from Neutral at Wedbush November 16, 2023TipRanks. Unity Biotechnology’s Promising Senolytic Therapy UBX1325 and Financial Stability Bolsters Buy ...Oct 5, 2022 · At $8, the average UBX price target implies upside potential of 1,829%. At writing, shares are trading at $0.41 for a market cap of approximately $56.8 million and has a 52-week range of $0.38 ... About Unity Biotechnology (UBX) Earnings Date, Estimates & Call Transcripts $1.92 0.00 (0.00%) (As of 12/1/2023 ET) Compare Today's Range $1.86 $2.04 50-Day …SOUTH SAN FRANCISCO, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse ...Nov 24, 2023 · UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds. SOUTH SAN FRANCISCO, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY” or the “Company”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or rev... 15 days ago - GlobeNewsWire. SOUTH SAN FRANCISCO, Calif., April 23, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...UBX. Unity Biotechnology, Inc. 1.8300 +0.1100 ... The S&P 500 has surged by 7% this month, while the tech-focused Nasdaq has shown even stronger growth, with gains of approximately 10%. Watching ...Mar 27, 2023 · UNITY to host investor call today, March 27, at 8:00 a.m. ET. SOUTH SAN FRANCISCO, Calif., March 27, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology ... May 1, 2021 · SOUTH SAN FRANCISCO, Calif., May 01, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse ... Nike, Inc. has no single specific owner. According to Nasdaq, the company is a publicly traded one, with its shares listed on the New York Stock Exchange under the symbol NKE. As of May, 2014, 83.29 percent of Nike’s shares were owned by in...Wedbush upgraded shares of Unity Biotechnology (NASDAQ:UBX – Free Report) from a neutral rating to an outperform rating in a report published on Thursday, Marketbeat reports. They currently have $4.00 price objective on the stock. Separately, HC Wainwright reiterated a buy rating and issued a $10.00 target price on shares of Unity ...According to the issued ratings of 4 analysts in the last year, the consensus rating for Unity Biotechnology stock is Buy based on the current 4 buy ratings for UBX. The average twelve-month price prediction for Unity Biotechnology is $6.50 with a high price target of $10.00 and a low price target of $4.00. Learn more on UBX's analyst rating ...Unity Biotechnology (NASDAQ:UBX) focuses primarily on the development of therapeutics that target age-related ophthalmologic and neurologic diseases. Its central candidate is UBX1325, currently ...The average one-year price target for Unity Biotechnology (NASDAQ:UBX) has been revised to 6.63 / share. This is an increase of 8.33% from the prior estimate of 6.12 dated October 31, 2023.May 1, 2021 · SOUTH SAN FRANCISCO, Calif., May 01, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse ... Source Headline; Unity Biotechnology (UBX) Price Target Increased by 8.33% to 6.63 msn.com - November 27 at 7:50 AM: Unity Biotechnology, Inc. Expected to Post FY2023 Earnings of ($2.66) Per Share (NASDAQ:UBX) americanbankingnews.com - November 20 at 1:26 AM Wedbush Upgrades Unity Biotechnology (UBX) msn.com - …View the latest Unity Biotechnology Inc. (UBX) stock price, news, historical charts, analyst ratings and financial information from WSJ.SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...SOUTH SAN FRANCISCO, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...SOUTH SAN FRANCISCO, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...SAN FRANCISCO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or ...SOUTH SAN FRANCISCO, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases ...Oct 19, 2022 · Follow. SOUTH SAN FRANCISCO, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY” or the “Company”) (Nasdaq:UBX), a biotechnology company developing therapeutics to ... SOUTH SAN FRANCISCO, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse ...TARGETING A ROOT CAUSE. Age-related diseases, such as vision loss and cognitive decline, cause considerable economic, personal, and societal burden for individuals, their families, and broader communities. By targeting age-related diseases, we believe that UNITY can treat these diseases, as well as contain healthcare costs and lessen the ...US Stock MarketDetailed Quotes. UBX Unity Biotechnology. Close 11 ... Wedbush analyst Andreas Argyrides upgraded the shares of Unity Biotechnology Inc (NASDAQ:UBX) ...Unity Biotechnology, Inc. Common Stock (UBX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.Nov 24, 2023 · UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds. SOUTH SAN FRANCISCO, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY” or the “Company”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or rev... 15 days ago - GlobeNewsWire. UNITY to host investor call today, March 27, at 8:00 a.m. ET. SOUTH SAN FRANCISCO, Calif., March 27, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology ...Amazon.com, Inc. (NASDAQ:AMZN) Shares Sold by EULAV Asset Management Charles Schwab Investment Management Inc. Purchases 226,874 Shares …7 ngày trước ... The average one-year price target for Unity Biotechnology (NASDAQ:UBX) has been revised to 6.63 / share. This is an increase of 8.33% from ...The latest price target for . Unity Biotechnology (NASDAQ: UBX) was reported by Wedbush on November 16, 2023.The analyst firm set a price target for $0.00 expecting UBX to fall to within 12 months ... Find the latest Insider Activity data for Unity Biotechnology, Inc. Common Stock (UBX) at Nasdaq.com.Cash used in operations during the first and second quarters of 2022 was $29.8 million compared to $28.5 million for the first and second quarters of 2021. Research and development expenses ...SAN FRANCISCO, June 18, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ: UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or ...SAN FRANCISCO, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting ...– Topline 12- and 24-week results expected in 2H 2020 – SAN FRANCISCO, March 31, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing ...NASDAQ 2.095 +0.035 +1.68% Opening 11:32 11/22 EST OPEN 2.080 PREV CLOSE 2.060 HIGH 2.119 LOW 2.070 VOLUME 14.63K TURNOVER 0 52 WEEK HIGH 5.72 52 WEEK …SOUTH SAN FRANCISCO, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...SOUTH SAN FRANCISCO, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...Mar 15, 2023 · SOUTH SAN FRANCISCO, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases ... SOUTH SAN FRANCISCO, Calif., Aug. 12, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...View the latest Unity Biotechnology Inc. (UBX) stock price, news, historical charts, analyst ratings and financial information from WSJ.Follow. SOUTH SAN FRANCISCO, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY” or the “Company”) (Nasdaq:UBX), a biotechnology company developing therapeutics to ...SOUTH SAN FRANCISCO, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse ...Real time Unity Biotechnology (UBX) stock price quote, stock graph, news & analysis.SOUTH SAN FRANCISCO, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...SOUTH SAN FRANCISCO, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse ...Dec 4, 2023 · In the previous quarter, Unity Biotechnology (NASDAQ:UBX) reported ($0.67) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.87) by $0.20. Learn more on analysts' earnings estimate vs. UBX's actual earnings. (NASDAQ: UBX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.13%. What is UBX's Price Target? According to 4 Wall Street analyst s that have issued a 1 year UBX price target, the average UBX price target is $7.00 , with the highest UBX stock price forecast at $10.00 and the lowest UBX stock price ... SAN FRANCISCO, Aug. 31, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or ...SOUTH SAN FRANCISCO, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases ...Mar 27, 2023 · UNITY to host investor call today, March 27, at 8:00 a.m. ET. SOUTH SAN FRANCISCO, Calif., March 27, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology ... SOUTH SAN FRANCISCO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...7 ngày trước ... The average one-year price target for Unity Biotechnology (NASDAQ:UBX) has been revised to 6.63 / share. This is an increase of 8.33% from ...SOUTH SAN FRANCISCO, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ...May 12, 2021 · NasdaqGS:UBX Insider Trading Volume May 12th 2021 I will like Unity Biotechnology better if I see some big insider buys. While we wait, check out this free list of growing companies with ... Nike, Inc. has no single specific owner. According to Nasdaq, the company is a publicly traded one, with its shares listed on the New York Stock Exchange under the symbol NKE. As of May, 2014, 83.29 percent of Nike’s shares were owned by in...SOUTH SAN FRANCISCO, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse ...SOUTH SAN FRANCISCO, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases ...ROTH CAPITAL PA WEDBUSH SECURIT Analyst Back to UBX Overview Analyst price targets provided by TipRanks. About Analyst Research Nasdaq Analyst Research …SOUTH SAN FRANCISCO, Calif., Aug. 12, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ...SOUTH SAN FRANCISCO, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...SOUTH SAN FRANCISCO, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the first quarter ended March 31, 2022.HC Wainwright restated their buy rating on shares of Unity Biotechnology (NASDAQ:UBX – Free Report) in a report published on Tuesday morning, Benzinga reports. HC Wainwright currently has a $10.00 price target on the stock. HC Wainwright also issued estimates for Unity Biotechnology’s Q4 2023 earnings at ($1.15) EPS, FY2024 earnings at ($3.83) EPS, FY2025 […]SAN FRANCISCO, June 18, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ: UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or ...SOUTH SAN FRANCISCO, Calif., July 31, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing ...Nasdaq ubx

Their UBX share price targets range from $4.00 to $10.00. On average, they anticipate the company's share price to reach $6.50 in the next twelve months. This suggests a possible upside of 226.6% from the stock's current price. View analysts price targets for UBX or view top-rated stocks among Wall Street analysts.. Nasdaq ubx

nasdaq ubx

NasdaqGS:UBX Insider Trading Volume May 12th 2021 I will like Unity Biotechnology better if I see some big insider buys. While we wait, check out this free list of growing companies with ...SOUTH SAN FRANCISCO, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases ...If you’re familiar with investing, then you’ve probably heard of major stock exchanges like the New York Stock Exchange or the NASDAQ. Stock exchanges are sort of like a mixture between an auction house and a marketplace where investors can...Unity Biotechnology (NASDAQ: UBX) stock is taking a beating on Monday after revealing results from its Phase 2 clinical trial of UBX1325. UBX1325 is a treatment in development that Unity is ...Oct. 23, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of ...Follow. SOUTH SAN FRANCISCO, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or ...Unity Biotechnology (NASDAQ:UBX) has observed the following analyst ratings within the last quarter: These 8 analysts have an average price target of $10.5 versus the current price of Unity ...Find the latest Institutional Holdings data for Unity Biotechnology, Inc. Common Stock (UBX) at Nasdaq.com. SOUTH SAN FRANCISCO, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...Nasdaq Fund Secondaries; Featured Solutions Nasdaq's IPO Process; ETF Listings; Nasdaq-100 Index Options; Derivatives AcademyUBX ( NASDAQ BIOTECH PENNY) crushes earnings and news catalyst NASDAQ:UBX and rises over 100 % in premarket, Has a new product for macular degeneration, a widespread medical problem affecting vision in the elderly which is increasing in incidence. The earning beat was significant.Their UBX share price targets range from $4.00 to $10.00. On average, they predict the company's stock price to reach $6.50 in the next year. This suggests a possible upside of 238.5% from the stock's current price. View analysts price targets for UBX or view top-rated stocks among Wall Street analysts.Jan 10, 2023 · Last November, Wedbush analyst Andreas Argyrides raised his price target on Unity Biotechnology, Inc. (NASDAQ:UBX) to $36 from $4 and maintained an Outperform rating on the shares. Overview Stock Screener Earnings Calendar Sectors Nasdaq | UBX U.S.: Nasdaq Unity Biotechnology Inc. Watch list NEW Set a price target alert After Hours Last Updated: Oct 27, 2023 7:54 p.m....Follow. SOUTH SAN FRANCISCO, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or ...(NASDAQ: UBX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.13%. What is UBX's Price Target? According to 4 Wall Street analyst s that have issued a 1 year UBX price target, the average UBX price target is $7.00 , with the highest UBX stock price forecast at $10.00 and the lowest UBX stock price ... UNITY’s common stock has been approved for listing on The Nasdaq Global Select Market and is expected to begin trading under the ticker symbol “UBX” on May 3, 2018.Jan 10, 2023 · Last November, Wedbush analyst Andreas Argyrides raised his price target on Unity Biotechnology, Inc. (NASDAQ:UBX) to $36 from $4 and maintained an Outperform rating on the shares. Nov 18, 2023 · HC Wainwright restated their buy rating on shares of Unity Biotechnology (NASDAQ:UBX – Free Report) in a report published on Tuesday morning, Benzinga reports. HC Wainwright currently has a $10.00 price target on the stock. HC Wainwright also issued estimates for Unity Biotechnology’s Q4 2023 earnings at ($1.15) EPS, FY2024 earnings at ($3.83) EPS, FY2025 […] SOUTH SAN FRANCISCO, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...Unity Biotechnology, Inc. (NASDAQ:UBX) shareholders should be happy to see the share price up 23% in the last month. But only the myopic could ignore the astounding decline over three years.SAN FRANCISCO, Aug. 04, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing ...SOUTH SAN FRANCISCO, Calif., Jan. 18, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...The average one-year price target for Unity Biotechnology (NASDAQ:UBX) has been revised to 6.63 / share. This is an increase of 8.33% from the prior estimate of 6.12 dated October 31, 2023. NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 1.9400 -0.0300 (-1.52%) At close: 04:00PM EST 1.9600 +0.02 (+1.03%) After hours: 07:11PM …SOUTH SAN FRANCISCO, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...52-week range: $0.42 – $3.64 Unity Biotechnology (NASDAQ:UBX) focuses primarily on the development of therapeutics that target age-related ophthalmologic and neurologic diseases.. Its central ...Stable Share Price: UBX is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week. Volatility Over Time : UBX's weekly …Unity Biotechnology (UBX) Insider Trading Activity 2023. MarketBeat Week in Review – 11/27 - 12/1. Teen girls are being victimized by deepfake nudes. One family is pushing for more protections. S&P 500 4,594.63. DOW 36,245.50.SOUTH SAN FRANCISCO, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...Unity Biotech sheds 48% after mid-stage setback for wet AMD candidate. Unity Biotechnology ( NASDAQ: UBX) lost ~48% pre-market Monday after announcing that its lead candidate UBX1325 failed to ...Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After Hours trades will be posted from 4:15 p.m. ET to 3:30 p.m. ET of the following day. Nov 20, 2023 · About the Company. Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company’s lead drug candidate includes UBX1325, which is phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema ... SOUTH SAN FRANCISCO, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...SOUTH SAN FRANCISCO, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of ...add_box. SOUTH SAN FRANCISCO, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...Enrollment of 51 patients exceeds target by ~10% due to high interest in the study. 16-week data anticipated in Q1 2023 and 24-week data anticipated in Q2 2023Jan 10, 2023 · Last November, Wedbush analyst Andreas Argyrides raised his price target on Unity Biotechnology, Inc. (NASDAQ:UBX) to $36 from $4 and maintained an Outperform rating on the shares. According to the issued ratings of 4 analysts in the last year, the consensus rating for Unity Biotechnology stock is Buy based on the current 4 buy ratings for UBX. The average twelve-month price prediction for Unity Biotechnology is $6.50 with a high price target of $10.00 and a low price target of $4.00. Learn more on UBX's analyst rating ...SOUTH SAN FRANCISCO, Calif. , Aug. 08, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the second quarter ended June 30, 2023 . June 21, 2023. UNITY Announces Design of …Unity Biotechnology (NASDAQ:UBX) has observed the following analyst ratings within the last quarter: These 8 analysts have an average price target of $10.5 versus the current price of Unity ...Oct. 23, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of ...Dec 2, 2020 · Unity Biotechnology, Inc. (NASDAQ: UBX) was in 5 hedge funds' portfolios at the end of September. The all time high for this statistics is 7. UBX investors should pay attention to a decrease in ... Cash used in operations during the first and second quarters of 2022 was $29.8 million compared to $28.5 million for the first and second quarters of 2021. Research and development expenses ...Unity Biotechnology Inc share price live 1.960, this page displays NASDAQ UBX stock exchange data. View the UBX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Unity Biotechnology Inc real time stock price chart below. You can find more details by visiting the additional ...Register for your free account today at data.nasdaq.com. About Pre-Market Quotes Nasdaq provides market information before market opens daily from 4:15 A.M. ET to …Mike Sapieha brings world-class expertise in aging-related ophthalmologic and neurologic diseases. UNITY also names Jason Damiano, Ph.D., as vice president of translational biology and Nathan Guz ...SOUTH SAN FRANCISCO, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing ...SAN FRANCISCO, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting ...SOUTH SAN FRANCISCO, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing ...Unity Biotechnology, Inc. (NASDAQ: UBX) is a South San Francisco based mid-clinical-stage healthcare concern developing treatments that “ slow, halt, or reverse diseases of aging,” with a ...SAN FRANCISCO, May 29, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or ...Nov 29, 2023 · See the latest Unity Biotechnology Inc stock price (UBX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. About Unity Biotechnology (UBX) Earnings Date, Estimates & Call Transcripts $1.92 0.00 (0.00%) (As of 12/1/2023 ET) Compare Today's Range $1.86 $2.04 50-Day …UNITY’s common stock has been approved for listing on The Nasdaq Global Select Market and is expected to begin trading under the ticker symbol “UBX” on May 3, 2018.SOUTH SAN FRANCISCO, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse ...The latest price target for . Unity Biotechnology (NASDAQ: UBX) was reported by Wedbush on November 16, 2023.The analyst firm set a price target for $0.00 expecting UBX to fall to within 12 months ...SOUTH SAN FRANCISCO, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse ...UNITY to host investor call today, March 27, at 8:00 a.m. ET. SOUTH SAN FRANCISCO, Calif., March 27, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology ...SOUTH SAN FRANCISCO, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...Find the latest Insider Activity data for Unity Biotechnology, Inc. Common Stock (UBX) at Nasdaq.com.SOUTH SAN FRANCISCO, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse ...Nike, Inc. has no single specific owner. According to Nasdaq, the company is a publicly traded one, with its shares listed on the New York Stock Exchange under the symbol NKE. As of May, 2014, 83.29 percent of Nike’s shares were owned by in...SOUTH SAN FRANCISCO, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY” or the “Company”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow ...Last November, Wedbush analyst Andreas Argyrides raised his price target on Unity Biotechnology, Inc. (NASDAQ:UBX) to $36 from $4 and maintained an Outperform rating on the shares.SAN FRANCISCO, May 26, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging ...UNITY to host investor call today, March 27, at 8:00 a.m. ET. SOUTH SAN FRANCISCO, Calif., March 27, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [Nasdaq: UBX], a biotechnology .... Invest in penny stocks app